Alzheimer’s Disease Clinical Trials
Advancing Alzheimer’s Research. Creating New Possibilities.
If you or a loved one has been diagnosed with Alzheimer’s disease, is experiencing changes in memory, or has concerns about future Alzheimer’s risk, you may be eligible for a clinical research study at NDx Clinical Research.
Alzheimer’s disease affects people differently—and research is evolving to address the disease at multiple stages. Our clinical research program offers opportunities ranging from studies for individuals who have not yet developed symptoms to trials for people living with Alzheimer’s disease and related symptoms.
Participation is always voluntary. Our research team will help you understand available studies and determine whether one may be an appropriate fit.
Currently Enrolling Alzheimer’s Studies
Our Alzheimer’s research program includes studies evaluating investigational approaches across different stages and symptoms of the disease.
MINDSET - Alzheimer’s Disease Study by Bristol Myers Squibb
For individuals living with Mild to Moderate Alzheimer’s disease
NDx is currently participating in a Bristol Myers Squibb clinical research study evaluating an investigational treatment for Alzheimer’s disease.
This study may be an option for individuals who have been diagnosed with Alzheimer’s disease and meet additional study-specific requirements.
Contact our Study Staff For More Information →
LIGHTHOUSE - Alzheimer’s Disease & Gum Health Study
For individuals with Mild to Moderate Alzheimer’s disease and evidence of gum disease
Researchers are studying the potential relationship between certain bacteria associated with gum disease and Alzheimer’s disease.
The Lighthouse study is evaluating an investigational treatment in individuals with Alzheimer’s disease who test positive for P. gingivalis, a bacterium associated with periodontal disease.
Study-related testing is used to determine whether an individual meets the specific requirements for participation.
Contact our Study Staff For More Information →
MAPLIGHT - Alzheimer’s Disease Psychosis Study
For individuals with Alzheimer’s disease experiencing hallucinations or delusions
Changes in memory and thinking are not the only symptoms that can occur with Alzheimer’s disease. Some individuals may also experience hallucinations, delusions, or other changes in their perception of reality.
NDx is conducting clinical research evaluating investigational treatment options specifically for Alzheimer’s disease psychosis.
A potential participant may be considered if they have Alzheimer’s disease and are experiencing symptoms such as:
-
Seeing or hearing things that others do not
-
Believing things that are not true or are inconsistent with reality
-
Increased suspiciousness or paranoia
-
Other hallucinations or delusional symptoms associated with Alzheimer’s disease
A caregiver or study partner may also be required to participate.
Contact our Study Staff For More Information →
Preclinical Alzheimer’s Disease Research
For individuals who do not have Alzheimer’s symptoms
Alzheimer’s-related changes in the brain can begin years before noticeable memory problems develop. Preclinical Alzheimer’s research focuses on this earlier stage of the disease.
NDx participates in research designed to identify and study individuals who may have biological evidence or an increased risk of Alzheimer’s disease but have not developed significant cognitive symptoms.
These studies are helping researchers better understand whether intervening earlier could affect the future course of Alzheimer’s disease.
If you are 55 years old or older, with family history of Alzheimer's Disease or an interest in proactive identification
Contact our Study Staff For More Information →
Not Sure Which Study Fits?
You do not need to know the name of a study or determine your own eligibility before contacting us.
Our research team can ask a few initial questions about your age, memory concerns, diagnosis, symptoms, medications, and medical history. From there, we can determine whether one of our currently enrolling studies may be worth exploring.
Even if one study isn't a match, another research opportunity may be available.
Find a Study →
What Does Participation Involve?
Every clinical trial is different. Before you decide whether to participate, our research team will explain the study in detail, including its purpose, requirements, potential risks and benefits, and expected time commitment.
Participation typically begins with an initial conversation with our research team. If a study appears to be a potential match, you may be invited to our research center to learn more.
Before any study-specific procedures are performed, you will review an informed consent form and have an opportunity to ask questions.
Additional screening may include medical history, memory or cognitive assessments, physical examinations, laboratory testing, imaging, or other evaluations depending on the study.
Participation is completely voluntary.
Who May Qualify?
Our Alzheimer’s research opportunities change throughout the year and may include studies for:
- Adults without noticeable memory problems who may be at increased risk for Alzheimer’s disease
- Individuals experiencing memory or thinking changes
- Individuals diagnosed with Mild Cognitive Impairment (MCI)
- Individuals diagnosed with mild, moderate, or more advanced Alzheimer’s disease
- Individuals experiencing behavioral symptoms associated with Alzheimer’s disease, including hallucinations, delusions, agitation, or other changes
- Care partners and family members supporting someone living with Alzheimer’s disease
You do not need to know your exact diagnosis or which study may be appropriate before contacting us. Our research team can help determine whether one of our current studies may be a potential fit.
Frequently Asked Questions
Do I need an Alzheimer’s diagnosis to participate?
Not necessarily. Eligibility depends on the individual study.
Some of our studies are designed for people who have been diagnosed with Alzheimer’s disease, while others may be appropriate for individuals experiencing memory changes or even people who have no noticeable symptoms.
Will I receive the investigational medication?
Not necessarily. Some clinical trials compare an investigational treatment with a placebo or another treatment. The research team will explain the design of a specific study before you decide whether to participate.
Is there a cost to participate?
Study-related procedures and investigational treatments are available at no cost. Insurance is not required nor collected by our study staff.
Will I be compensated?
Compensation for time and travel may be available depending on the study. The amount and requirements vary by clinical trial and will be reviewed with you before participation.
Does a caregiver need to participate?
Many Alzheimer’s clinical trials require a study partner or caregiver who knows the participant well and can attend certain study visits.
Requirements vary by study, and our team can explain what is expected during your initial conversation.
Can I change my mind after joining?
Yes. Clinical trial participation is voluntary. You may decide not to participate or withdraw from a study at any time.
Take the First Step
You don't have to determine whether you qualify on your own.
If you or someone you care for has Alzheimer’s disease, has noticed changes in memory, is experiencing hallucinations or delusions associated with Alzheimer’s disease, or is interested in research before symptoms develop, our team can help you explore current opportunities.
Call 937-224-8200, ext. 5 for Clinical Research
See If You May Qualify →